These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 3568456

  • 1. Circulating serum amyloid P component is the precursor of amyloid P component in tissue amyloid deposits.
    Baltz ML, Caspi D, Evans DJ, Rowe IF, Hind CR, Pepys MB.
    Clin Exp Immunol; 1986 Dec; 66(3):691-700. PubMed ID: 3568456
    [Abstract] [Full Text] [Related]

  • 2. Use of genetically altered mice to study the role of serum amyloid P component in amyloid deposition.
    Maeda S.
    Amyloid; 2003 Aug; 10 Suppl 1():17-20. PubMed ID: 14640037
    [Abstract] [Full Text] [Related]

  • 3. Differences in the acute phase responses of serum amyloid P-component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and -resistant mouse strains.
    Baltz ML, Gomer K, Davies AJ, Evans DJ, Klaus GG, Pepys MB.
    Clin Exp Immunol; 1980 Feb; 39(2):355-60. PubMed ID: 7389204
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component.
    Hawkins PN, Myers MJ, Epenetos AA, Caspi D, Pepys MB.
    J Exp Med; 1988 Mar 01; 167(3):903-13. PubMed ID: 3351437
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor.
    Sørby R, Espenes A, Landsverk T, Westermark G.
    Amyloid; 2008 Mar 01; 15(1):20-8. PubMed ID: 18266118
    [Abstract] [Full Text] [Related]

  • 11. Pathogenesis, diagnosis and treatment of systemic amyloidosis.
    Pepys MB.
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb 28; 356(1406):203-10; discussion 210-1. PubMed ID: 11260801
    [Abstract] [Full Text] [Related]

  • 12. Formation of experimental murine AA amyloid fibrils in SAP-deficient mice: high resolution ultrastructural study.
    Inoue S, Kawano H, Ishihara T, Maeda S, Ohno S.
    Amyloid; 2005 Sep 28; 12(3):157-63. PubMed ID: 16194870
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Amyloid enhancing factor is produced by rats and amyloid-resistant CE/J mice.
    Gonnerman WA, Kandel R, Cathcart ES.
    Lab Invest; 1996 Jan 28; 74(1):259-64. PubMed ID: 8569190
    [Abstract] [Full Text] [Related]

  • 18. Demonstration of amyloid A (AA) protein and amyloid P component (AP) in deposits of systemic amyloidosis associated with renal adenocarcinoma.
    Hind CR, Tennent GA, Evans DJ, Pepys MB.
    J Pathol; 1983 Feb 28; 139(2):159-66. PubMed ID: 6338184
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.